Abstract
Esophagogastric junctional cancer is classified into three categories according to the Siewert classification, which reflects the epidemiological and biological characteristics. Therapeutic strategies have been evaluated according to the three Siewert types. There is a consensus that types I and III should be treated as esophageal cancer and gastric cancer, respectively. On the other hand, type II is often described as true cardiac cancer, which has different clinicopathological features from the other types. Thus, there is no consensus on the surgical management of type II esophagogastric junctional cancer. The optimal surgical management should focus on the principles of cancer surgery, which take into consideration oncological curability, including an appropriate resection margin, adequate lymphadenectomy, and minimization of postoperative complications. In this review, we evaluate the current relevant literature and evidence, on the surgical treatment of esophagogastric junctional cancer, focusing on type II. Esophagectomy with a thoracic approach has the advantage of ensuring a sufficient proximal resection margin and adequate mediastinal lymphadenectomy. However, the oncological benefit is offset by a high incidence of postoperative complications. Minimally invasive esophagectomy could be a possible solution to reduce complications and improve long-term outcomes. Further development of surgical treatments for Siewert type II is required to improve the outcomes. Furthermore, the surgical team should have expertise in both gastric cancer and esophageal cancer treatment, or patients should be managed with close collaboration between thoracic surgeons and gastric cancer surgeons.
Similar content being viewed by others
References
Giacopuzzi S, Bencivenga M, Weindelmayer J et al (2017) Western strategy for EGJ carcinoma. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 20:60–68
Siewert JR, Stein HJ (1998) Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg 85:1457–1459
McColl KE, Going JJ (2010) Aetiology and classification of adenocarcinoma of the gastro-oesophageal junction/cardia. Gut 59:282–284
Leers JM, DeMeester SR, Chan N et al (2009) Clinical characteristics, biologic behavior, and survival after esophagectomy are similar for adenocarcinoma of the gastroesophageal junction and the distal esophagus. J Thorac Cardiovasc Surg 138:594–602 (discussion 601 592)
Wong CL, Law S (2019) Extent of lymphadenectomy for Barrett’s cancer. Translational gastroenterology and hepatology 4:36
Zanoni A, Verlato G, Giacopuzzi S et al (2013) Neoadjuvant concurrent chemoradiotherapy for locally advanced esophageal cancer in a single high-volume center. Ann Surg Oncol 20:1993–1999
Barbour AP, Rizk NP, Gonen M et al (2007) Adenocarcinoma of the gastroesophageal junction: influence of esophageal resection margin and operative approach on outcome. Ann Surg 246:1–8
de Manzoni G, Pedrazzani C, Pasini F et al (2002) Results of surgical treatment of adenocarcinoma of the gastric cardia. Ann Thorac Surg 73:1035–1040
Feith M, Stein HJ, Siewert JR (2003) Pattern of lymphatic spread of Barrett’s cancer. World J Surg 27:1052–1057
Pedrazzani C, de Manzoni G, Marrelli D et al (2007) Lymph node involvement in advanced gastroesophageal junction adenocarcinoma. J Thorac Cardiovasc Surg 134:378–385
Grotenhuis BA, Wijnhoven BP, Poley JW et al (2013) Preoperative assessment of tumor location and station-specific lymph node status in patients with adenocarcinoma of the gastroesophageal junction. World J Surg 37:147–155
Cense HA, Sloof GW, Klaase JM et al (2004) Lymphatic drainage routes of the gastric cardia visualized by lymphoscintigraphy. Journal of nuclear medicine : official publication, Society of Nuclear Medicine 45:247–252
Feith M, Stein HJ, Siewert JR (2006) Adenocarcinoma of the esophagogastric junction: surgical therapy based on 1602 consecutive resected patients. Surg Oncol Clin N Am 15:751–764
Kakeji Y, Yamamoto M, Ito S et al (2012) Lymph node metastasis from cancer of the esophagogastric junction, and determination of the appropriate nodal dissection. Surg Today 42:351–358
Fujitani K, Miyashiro I, Mikata S et al (2013) Pattern of abdominal nodal spread and optimal abdominal lymphadenectomy for advanced Siewert type II adenocarcinoma of the cardia: results of a multicenter study. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 16:301–308
Goto H, Tokunaga M, Sugisawa N et al (2013) Value of splenectomy in patients with Siewert type II adenocarcinoma of the esophagogastric junction. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 16:590–595
Hasegawa S, Yoshikawa T, Rino Y et al (2013) Priority of lymph node dissection for Siewert type II/III adenocarcinoma of the esophagogastric junction. Ann Surg Oncol 20:4252–4259
Mine S, Sano T, Hiki N et al (2013) Lymphadenectomy around the left renal vein in Siewert type II adenocarcinoma of the oesophagogastric junction. Br J Surg 100:261–266
Goto H, Tokunaga M, Miki Y et al (2014) The optimal extent of lymph node dissection for adenocarcinoma of the esophagogastric junction differs between Siewert type II and Siewert type III patients. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 18:375–381
Parry K, Haverkamp L, Bruijnen RC et al (2015) Surgical treatment of adenocarcinomas of the gastro-esophageal junction. Ann Surg Oncol 22:597–603
Yoshikawa T, Takeuchi H, Hasegawa S et al (2016) Theoretical therapeutic impact of lymph node dissection on adenocarcinoma and squamous cell carcinoma of the esophagogastric junction. Gas Cancer 19:143–149
Yamashita H, Seto Y, Sano T et al (2017) Results of a nation-wide retrospective study of lymphadenectomy for esophagogastric junction carcinoma. Gas Cancer 20:69–83
Kurokawa Y, Takeuchi H, Doki Y et al (2021) Mapping of lymph node metastasis from esophagogastric junction tumors: a prospective nationwide multicenter study. Ann Surg 274:120–127
Gao F, Chen J, Wang T et al (2014) Incidence of microscopically positive proximal margins in adenocarcinoma of the gastroesophageal junction. PloS one 9:e88010
Mariette C, Castel B, Balon JM et al (2003) Extent of oesophageal resection for adenocarcinoma of the oesophagogastric junction. Eur J Surg Oncol 29:588–593
Ito H, Clancy TE, Osteen RT et al (2004) Adenocarcinoma of the gastric cardia: what is the optimal surgical approach? J Am Coll Surg 199:880–886
Mine S, Sano T, Hiki N et al (2013) Proximal margin length with transhiatal gastrectomy for Siewert type II and III adenocarcinomas of the oesophagogastric junction. Br J Surg 100:1050–1054
Siu KF, Cheung HC, Wong J (1986) Shrinkage of the esophagus after resection for carcinoma. Ann Surg 203:173–176
Hulscher JB, van Sandick JW, de Boer AG et al (2002) Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 347:1662–1669
Sasako M, Sano T, Yamamoto S et al (2006) Left thoracoabdominal approach versus abdominal-transhiatal approach for gastric cancer of the cardia or subcardia: a randomised controlled trial. Lancet Oncol 7:644–651
Heger P, Blank S, Gooßen K et al (2019) Thoracoabdominal versus transhiatal surgical approaches for adenocarcinoma of the esophagogastric junction-a systematic review and meta-analysis. Langenbecks Arch Surg 404:103–113
Kinjo Y, Kurita N, Nakamura F et al (2012) Effectiveness of combined thoracoscopic-laparoscopic esophagectomy: comparison of postoperative complications and midterm oncological outcomes in patients with esophageal cancer. Surg Endosc 26:381–390
Sihag S, Wright CD, Wain JC et al (2012) Comparison of perioperative outcomes following open versus minimally invasive Ivor Lewis oesophagectomy at a single, high-volume centre. Eur J Cardiothorac Surg 42:430–437
Ichikawa H, Miyata G, Miyazaki S et al (2013) Esophagectomy using a thoracoscopic approach with an open laparotomic or hand-assisted laparoscopic abdominal stage for esophageal cancer: analysis of survival and prognostic factors in 315 patients. Ann Surg 257:873–885
Lee L, Sudarshan M, Li C et al (2013) Cost-effectiveness of minimally invasive versus open esophagectomy for esophageal cancer. Ann Surg Oncol 20:3732–3739
Meng F, Li Y, Ma H et al (2014) Comparison of outcomes of open and minimally invasive esophagectomy in 183 patients with cancer. J Thorac Dis 6:1218–1224
Biere SS, van Berge Henegouwen MI, Maas KW et al (2012) Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial. Lancet (London, England) 379:1887–1892
Haverkamp L, Seesing MF, Ruurda JP et al (2017) Worldwide trends in surgical techniques in the treatment of esophageal and gastroesophageal junction cancer. Dis Esophagus 30:1–7
Author information
Authors and Affiliations
Corresponding authors
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Hayashi, T., Yoshikawa, T. Optimal surgery for esophagogastric junctional cancer. Langenbecks Arch Surg 407, 1399–1407 (2022). https://doi.org/10.1007/s00423-021-02375-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00423-021-02375-7